Incontinence, comorbidities and parental stress in children and adolescents with Attention Deficit Hyperactivity Disoder (ADHD)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015321

Enrollment

160

Registered

2018-09-19

Start date

2018-10-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F98.0 N39.4 F90.0 F90.1 F98.8 F98.1

Interventions

Group 1: 80 children / adolescents with tentative or confirmed AD(H)D, who introduce themselves at our out-patient clinic, are asked to participate once in the following assessments: Children / Adol

2. Uroflow

3. Abdominal Sonography (bladder, bladder wall, rectum, residual urine)

4. General somatic Screening (internal and neurological)

Parents: 1. General psychiatric interview (Kinder-DIPS)

2. Child Behavior Checklist 4-18 (CBCL)

3. Enuresis / Encopresis Questionnaire to assess ROME-IV- and ICCS-criteria

4. 48 hour micturition protocol

5. Parental Questionnaire about ADHD symptoms (DISYPS-II-FBB-ADHS)

6. Assessment of parental distress (Elternstressfragebogen, ESF). Group 2: 80 typically developed children / adolescents are asked to participate once in the following assessments: Children / Adol

3. Abdominal sonography (bladder, bladder wall, rectum, residual urine)

6. Assessment of parental distress (Elternstressfragebogen, ESF).

Eligibility

Sex/Gender

All

Age

5 Years to 18 Years

Inclusion criteria

Inclusion criteria: In the clinical sample: A tentative or confirmed Disorder of activity and attention (F90.0), Hyperkinetic conduct disorder (F90.1) or Attention deficit withour hyperactivity (F98.8). In the control Group: Exclusion of a Disorder of activity and attention (F90.0), Hyperkinetic conduct disorder (F90.1) or Attention deficit withour hyperactivity (F98.8).

Exclusion criteria

Exclusion criteria: 1.) Severe somatic diseases; 2.) Mental disability (IQ < 70).

Design outcomes

Secondary

Measure	Time frame
1.) Psychiatric comorbidities or psychopathological symptoms in children and adolescents with AD(H)D (F90.0; F90.1; F98.8) and / or incontinence (F98.0; N39.4; F98.1). 2.) Degree of parental distress in children with a) AD(H)D, b) Enuresis / Daytime urinary incontinence / Encopresis, and c) children with AD(H)D and comorbid incontinence.	—

Primary

Measure	Time frame
1.) Prevalence of incontinence (Enuresis: F98.0; Daytime urinary incontinence: N39.4; Encopresis: F98.1) in children with AD(H)D (Disturbance of activity and attention: F90.0; Hyperkinetic conduct disorder: F90.1; Attention deficit disorder without hyperactivity: F98.8).	—

Countries

Germany

Contacts

Public ContactAlisha Rosenthal

Lehrstuhl und Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik am Universitätsklinikum des Saarlandes

alisha.rosenthal@uks.eu06841-1624216

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026